23 reports of this reaction
3.8% of all FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE reports
#5 most reported adverse reaction
ACUTE KIDNEY INJURY is the #5 most commonly reported adverse reaction for FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE, manufactured by HyVee Inc. There are 23 FDA adverse event reports linking FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE to ACUTE KIDNEY INJURY. This represents approximately 3.8% of all 604 adverse event reports for this drug.
Patients taking FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE who experience acute kidney injury should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ACUTE KIDNEY INJURY is moderately reported among FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE users, representing a notable but not dominant share of adverse events.
In addition to acute kidney injury, the following adverse reactions have been reported for FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE:
The following drugs have also been linked to acute kidney injury in FDA adverse event reports:
ACUTE KIDNEY INJURY has been reported as an adverse event in 23 FDA reports for FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ACUTE KIDNEY INJURY accounts for approximately 3.8% of all adverse event reports for FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE, making it a notable side effect.
If you experience acute kidney injury while taking FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.